Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 113,548 shares at $22.48 ($2.5M) on 2023-08-30, disclosed to the SEC on 2023-09-01.
Open-market sale of $2.5M IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.97 | 50,866 | $1.1M | 44.7% |
| 2 | $21.97 | 50,866 | $1.1M | 44.7% |
| 3 | $22.48 | 5,908 | $133K | 5.3% |
| 4 | $22.48 | 5,908 | $133K | 5.3% |
| Total | $22.02 avg | 113,548 | $2.5M | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |